Background Newborn bloodspot screening (NBS) for cystic fibrosis (CF) was introduced across the UK in 2007 but the impact on clinical outcomes and health inequalities for children with CF is unclear.
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback